Financial results for the period ended March 31, 2026
As filed · Epigral Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
What happened
FactEpigral Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Sub.: Outcome of Board Meeting held on Saturday, 2nd May, 2026 and submission of. Recommended Final dividend of Rs. 5.00 (50%) per Equity Share of face value of Rs. 10/-.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
Delayedwe expect the macroeconomic environment will stabilize and improve as we move forward.
PAT grew by 25% to INR99 crores versus comparable adjusted PAT of INR79 crores in Q1 '26.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- The company expects to commission both the commercial plant in H2FY28. (management committed by H2 FY28)
- We expect H2FY26 to be stronger compared to H1FY26. (management committed by H2 FY26)
Evidence
- Epigral Limited has informed the Exchange that Board of Directors at its meeting held on May 02, 2026, recommended Final Dividend of Rs. 5 per equity share.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%